Dr. Kasper on Future Treatment Approaches in Sarcoma

Bernd Kasper, MD, PhD
Published: Wednesday, May 17, 2017



Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, discusses future treatment approaches in the field of sarcoma and the potential role of imatinib (Gleevac).

There are interesting data looking at Notch inhibition with a gamma secretase inhibitor in a small, phase II study of 17 patients, which demonstrated an overall response rate of 29%. Hopefully, this will lead to a larger study, Kasper adds, that could show that this could be an effective treatment option for patients.

Moreover, tyrosine kinase inhibitors, such as imatinib could also hold promise in patients with desmoid tumors, specifically in those who have progressive disease. However, this needs to be built into a strategy and used appropriately on an individualized basis, Kasper explains.


Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, discusses future treatment approaches in the field of sarcoma and the potential role of imatinib (Gleevac).

There are interesting data looking at Notch inhibition with a gamma secretase inhibitor in a small, phase II study of 17 patients, which demonstrated an overall response rate of 29%. Hopefully, this will lead to a larger study, Kasper adds, that could show that this could be an effective treatment option for patients.

Moreover, tyrosine kinase inhibitors, such as imatinib could also hold promise in patients with desmoid tumors, specifically in those who have progressive disease. However, this needs to be built into a strategy and used appropriately on an individualized basis, Kasper explains.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x